Adeno-Associated Virus —Mediated Gene Transfer for Hemophilia B
- 1 November 2002
- journal article
- review article
- Published by Springer Science and Business Media LLC in International Journal of Hematology
- Vol. 76 (4), 310-318
- https://doi.org/10.1007/bf02982689
Abstract
No abstract availableKeywords
This publication has 70 references indexed in Scilit:
- Influence of Vector Dose on Factor IX-Specific T and B Cell Responses in Muscle-Directed Gene TherapyHuman Gene Therapy, 2002
- Muscle-Directed Gene Transfer and Transient Immune Suppression Result in Sustained Partial Correction of Canine Hemophilia B Caused by a Null MutationMolecular Therapy, 2001
- Observed incidence of tumorigenesis in long-term rodent studies of rAAV vectorsGene Therapy, 2001
- High Plasma Levels of Factor VIII and the Risk of Recurrent Venous ThromboembolismThe New England Journal of Medicine, 2000
- Sustained Expression of Therapeutic Level of Factor IX in Hemophilia B Dogs by AAV-Mediated Gene Therapy in LiverMolecular Therapy, 2000
- A Phase I/II Study of tgAAV-CF for the Treatment of Chronic Sinusitis in Patients with Cystic Fibrosis. Stanford University, Stanford, CaliforniaHuman Gene Therapy, 1998
- Haemophilia prophylaxis in young patients–a long‐term follow‐upJournal of Internal Medicine, 1997
- An algorithm for the grading of activity in chronic hepatitis CHepatology, 1996
- WHY DO SO MANY HAEMOPHILIA A PATIENTS DEVELOP AN INHIBITOR?British Journal of Haematology, 1995
- Characterization of the human factor VIII geneNature, 1984